BRCA1
Summary: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2009].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
BRCA1, DNA repair associated | MIM:113705 | Ensembl:ENSG00000012048 | HGNC:HGNC:1100 | PA25411 | 17q21.31 |
GO terms in BRCA1
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | TAS | GO:0003677 | DNA binding |
MF | IEA | GO:0003684 | damaged DNA binding |
MF | IMP | GO:0003713 | transcription coactivator activity |
MF | NAS | GO:0003713 | transcription coactivator activity |
MF | IDA | GO:0003723 | RNA binding |
MF | IBA | GO:0004842 | ubiquitin-protein transferase activity |
MF | IDA | GO:0004842 | ubiquitin-protein transferase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0008270 | zinc ion binding |
MF | NAS | GO:0015631 | tubulin binding |
MF | IPI | GO:0019899 | enzyme binding |
MF | IPI | GO:0031625 | ubiquitin protein ligase binding |
MF | IDA | GO:0044212 | transcription regulatory region DNA binding |
MF | NAS | GO:0050681 | androgen receptor binding |
MF | IDA | GO:0070063 | RNA polymerase binding |
CC | NAS | GO:0000151 | ubiquitin ligase complex |
CC | IDA | GO:0000800 | lateral element |
CC | IDA | GO:0005634 | nucleus |
CC | TAS | GO:0005654 | nucleoplasm |
CC | ISS | GO:0005694 | chromosome |
CC | IDA | GO:0005737 | cytoplasm |
CC | IBA | GO:0005886 | plasma membrane |
CC | IDA | GO:0005886 | plasma membrane |
CC | NAS | GO:0008274 | gamma-tubulin ring complex |
CC | IBA | GO:0031436 | BRCA1-BARD1 complex |
CC | IDA | GO:0031436 | BRCA1-BARD1 complex |
CC | IDA | GO:0032991 | protein-containing complex |
CC | IBA | GO:0070531 | BRCA1-A complex |
CC | IDA | GO:0070531 | BRCA1-A complex |
CC | IDA | GO:1990904 | ribonucleoprotein complex |
BP | IBA | GO:0000724 | double-strand break repair via homologous recombination |
BP | IDA | GO:0000724 | double-strand break repair via homologous recombination |
BP | TAS | GO:0000729 | DNA double-strand break processing |
BP | TAS | GO:0006260 | DNA replication |
BP | IDA | GO:0006301 | postreplication repair |
BP | IDA | GO:0006302 | double-strand break repair |
BP | IMP | GO:0006302 | double-strand break repair |
BP | TAS | GO:0006303 | double-strand break repair via nonhomologous end joining |
BP | IEA | GO:0006349 | regulation of gene expression by genetic imprinting |
BP | IEA | GO:0006351 | transcription, DNA-templated |
BP | IMP | GO:0006357 | regulation of transcription by RNA polymerase II |
BP | TAS | GO:0006359 | regulation of transcription by RNA polymerase III |
BP | IEA | GO:0006633 | fatty acid biosynthetic process |
BP | TAS | GO:0006915 | apoptotic process |
BP | TAS | GO:0006974 | cellular response to DNA damage stimulus |
BP | TAS | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
BP | IMP | GO:0007059 | chromosome segregation |
BP | IEA | GO:0007098 | centrosome cycle |
BP | IDA | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
BP | IBA | GO:0009048 | dosage compensation by inactivation of X chromosome |
BP | IMP | GO:0010212 | response to ionizing radiation |
BP | IMP | GO:0010575 | positive regulation of vascular endothelial growth factor production |
BP | IMP | GO:0010628 | positive regulation of gene expression |
BP | IDA | GO:0016567 | protein ubiquitination |
BP | TAS | GO:0016579 | protein deubiquitination |
BP | NAS | GO:0030521 | androgen receptor signaling pathway |
BP | IDA | GO:0031398 | positive regulation of protein ubiquitination |
BP | IMP | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway |
BP | IBA | GO:0035066 | positive regulation of histone acetylation |
BP | IDA | GO:0035066 | positive regulation of histone acetylation |
BP | IBA | GO:0035067 | negative regulation of histone acetylation |
BP | TAS | GO:0042127 | regulation of cell proliferation |
BP | TAS | GO:0042981 | regulation of apoptotic process |
BP | IBA | GO:0043009 | chordate embryonic development |
BP | IDA | GO:0043627 | response to estrogen |
BP | IEA | GO:0044030 | regulation of DNA methylation |
BP | IEA | GO:0044818 | mitotic G2/M transition checkpoint |
BP | IBA | GO:0045717 | negative regulation of fatty acid biosynthetic process |
BP | IMP | GO:0045717 | negative regulation of fatty acid biosynthetic process |
BP | IMP | GO:0045739 | positive regulation of DNA repair |
BP | IMP | GO:0045766 | positive regulation of angiogenesis |
BP | IDA | GO:0045892 | negative regulation of transcription, DNA-templated |
BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | NAS | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | TAS | GO:0045893 | positive regulation of transcription, DNA-templated |
BP | IBA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IDA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | IMP | GO:0045944 | positive regulation of transcription by RNA polymerase II |
BP | NAS | GO:0046600 | negative regulation of centriole replication |
BP | IDA | GO:0051571 | positive regulation of histone H3-K4 methylation |
BP | IEA | GO:0051572 | negative regulation of histone H3-K4 methylation |
BP | IDA | GO:0051573 | negative regulation of histone H3-K9 methylation |
BP | IEA | GO:0051574 | positive regulation of histone H3-K9 methylation |
BP | IDA | GO:0051865 | protein autoubiquitination |
BP | TAS | GO:0070317 | negative regulation of G0 to G1 transition |
BP | IDA | GO:0070512 | positive regulation of histone H4-K20 methylation |
BP | IBA | GO:0071158 | positive regulation of cell cycle arrest |
BP | IDA | GO:0071158 | positive regulation of cell cycle arrest |
BP | IMP | GO:0071356 | cellular response to tumor necrosis factor |
BP | IDA | GO:0071681 | cellular response to indole-3-methanol |
BP | IMP | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint |
BP | IDA | GO:0085020 | protein K6-linked ubiquitination |
BP | IMP | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
BP | IMP | GO:2000378 | negative regulation of reactive oxygen species metabolic process |
BP | IDA | GO:2000617 | positive regulation of histone H3-K9 acetylation |
BP | IDA | GO:2000620 | positive regulation of histone H4-K16 acetylation |
Gene expression in normal tissue: BRCA1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in BRCA1
Database | Pathway ID | Pathway Des. |
---|---|---|
biocarta | atmpathway | atm signaling pathway |
biocarta | atrbrcapathway | role of brca1 brca2 and atr in cancer susceptibility |
biocarta | bard1pathway | brca1 dependent ub ligase activity |
biocarta | g2pathway | cell cycle: g2/m checkpoint |
reactome | R-HSA-1221632 | Meiotic synapsis |
reactome | R-HSA-1474165 | Reproduction |
reactome | R-HSA-1500620 | Meiosis |
reactome | R-HSA-1640170 | Cell Cycle |
reactome | R-HSA-1640170 | Cell Cycle |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-2990846 | SUMOylation |
reactome | R-HSA-3108214 | SUMOylation of DNA damage response and repair proteins |
reactome | R-HSA-3108232 | SUMO E3 ligases SUMOylate target proteins |
reactome | R-HSA-3700989 | Transcriptional Regulation by TP53 |
reactome | R-HSA-392499 | Metabolism of proteins |
reactome | R-HSA-5633007 | Regulation of TP53 Activity |
reactome | R-HSA-5685938 | HDR through Single Strand Annealing (SSA) |
reactome | R-HSA-5685942 | HDR through Homologous Recombination (HRR) |
reactome | R-HSA-5688426 | Deubiquitination |
reactome | R-HSA-5689901 | Metalloprotease DUBs |
reactome | R-HSA-5693532 | DNA Double-Strand Break Repair |
reactome | R-HSA-5693537 | Resolution of D-Loop Structures |
reactome | R-HSA-5693538 | Homology Directed Repair |
reactome | R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) |
reactome | R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks |
reactome | R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) |
reactome | R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates |
reactome | R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) |
reactome | R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange |
reactome | R-HSA-5693606 | DNA Double Strand Break Response |
reactome | R-HSA-5693607 | Processing of DNA double-strand break ends |
reactome | R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange |
reactome | R-HSA-597592 | Post-translational protein modification |
reactome | R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes |
reactome | R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation |
reactome | R-HSA-69473 | G2/M DNA damage checkpoint |
reactome | R-HSA-69481 | G2/M Checkpoints |
reactome | R-HSA-69620 | Cell Cycle Checkpoints |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-73894 | DNA Repair |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-8953750 | Transcriptional Regulation by E2F6 |
reactome | R-HSA-912446 | Meiotic recombination |
wikipathways | WP138 | Androgen receptor signaling pathway |
wikipathways | WP1530 | miRNA Regulation of DNA Damage Response |
wikipathways | WP2261 | Signaling Pathways in Glioblastoma |
wikipathways | WP3646 | Hepatitis C and Hepatocellular Carcinoma |
wikipathways | WP3651 | Pathways Affected in Adenoid Cystic Carcinoma |
wikipathways | WP3808 | TP53 Regulates Transcription of DNA Repair Genes |
wikipathways | WP4172 | PI3K-Akt Signaling Pathway |
wikipathways | WP707 | DNA Damage Response |
pid | ar_pathway | Coregulation of Androgen receptor activity |
pid | atf2_pathway | ATF-2 transcription factor network |
pid | atm_pathway | ATM pathway |
pid | aurora_a_pathway | Aurora A signaling |
pid | bard1pathway | BARD1 signaling events |
pid | e2f_pathway | E2F transcription factor network |
pid | era_genomic_pathway | Validated nuclear estrogen receptor alpha network |
pid | fanconi_pathway | Fanconi anemia pathway |
pid | hnf3apathway | FOXA1 transcription factor network |
pid | myc_represspathway | Validated targets of C-MYC transcriptional repression |
kegg | hsa03440 | Homologous recombination - Homo sapiens (human) |
kegg | hsa03460 | Fanconi anemia pathway - Homo sapiens (human) |
kegg | hsa04120 | Ubiquitin mediated proteolysis - Homo sapiens (human) |
kegg | hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
kegg | hsa05206 | MicroRNAs in cancer - Homo sapiens (human) |
kegg | hsa05224 | Breast cancer - Homo sapiens (human) |
netpath | Pathway_AndrogenReceptor | AndrogenReceptor |
netpath | Pathway_TGF_beta_Receptor | TGF_beta_Receptor |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD193 | Fqi1 | 2 |
iGMDRD686 | PF4708671 | 1 |
iGMDRD281 | Vinorelbine base | 1 |
iGMDRD446 | LY 2183240 | 3 |
iGMDRD375 | GW-405833 | 3 |
iGMDRD280 | CYTOCHALASIN B | 2 |
iGMDRD387 | CHIR-99021 | 2 |
iGMDRD971 | PARP inhibitor | 16 |
iGMDRD398 | Sepantronium | 2 |
iGMDRD562 | Navitoclax | 3 |
iGMDRD411 | Platinum Agent | 6 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD887 | Compound 23 citrate | 3 |
iGMDRD100 | Zebularine | 2 |
iGMDRD60 | Quinoclamine | 4 |
iGMDRD138 | PX 12 | 3 |
iGMDRD318 | PAC-1 | 5 |
iGMDRD211 | (1S,3R)-RSL3 | 2 |
iGMDRD901 | ELCPK | 1 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD307 | Manumycin A | 2 |
iGMDRD84 | Lovastatin acid | 2 |
iGMDRD382 | CEP-701 | 1 |
iGMDRD424 | Tamatinib | 1 |
iGMDRD160 | Cis-Platin | 3 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 4 |
iGMDRD42 | Vorinostat | 1 |
iGMDRD300 | Tozasertib | 2 |
iGMDRD479 | Veliparib | 2 |
iGMDRD381 | Rucaparib | 7 |
iGMDRD267 | Oligomycin A | 3 |
iGMDRD434 | BMS-536924 | 7 |
iGMDRD62 | Platinum | 2 |
iGMDRD152 | 179324-69-7 | 1 |
iGMDRD1033 | WEE1 inhibitor | 2 |
iGMDRD639 | YK 4-279 | 3 |
iGMDRD433 | Lexibulin | 4 |
iGMDRD781 | Sirolimus | 2 |
iGMDRD546 | BMS-754807 | 1 |
iGMDRD506 | Fedratinib | 10 |
iGMDRD74 | Idarubicin | 4 |
iGMDRD730 | Kahalalide F | 1 |
iGMDRD356 | PNU-74654 | 3 |
iGMDRD64 | Parbendazole | 5 |
iGMDRD474 | Avrainvillamide | 2 |
iGMDRD117 | Docetaxel | 1 |
iGMDRD383 | Cediranib | 1 |
iGMDRD123 | Isoevodiamine | 5 |
iGMDRD879 | chemotherapy | 4 |
iGMDRD584 | VER 155008 | 3 |
iGMDRD330 | BRD4132 | 2 |
iGMDRD79 | Gemcitabine | 3 |
iGMDRD583 | LDN 193189 | 2 |
iGMDRD150 | RITA | 3 |
iGMDRD560 | MK-2206 | 1 |
iGMDRD532 | Olaparib | 18 |
iGMDRD329 | Merck60 | 7 |
iGMDRD331 | Taxane | 1 |
iGMDRD286 | Nsc 632839 | 8 |
iGMDRD202 | Curcumin | 1 |
iGMDRD137 | Indisulam | 7 |
iGMDRD251 | ML162 | 2 |
iGMDRD77 | Itraconazole | 2 |
iGMDRD288 | Carboplatin | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in BRCA1